Latest In: Royal Emerald Pharmaceuticals

Image of University of Mississippi research crops

Can DEA-backed cannabis growers strike gold via drug development?

The cannabis industry hit a possible milestone in March when Bright Green Corp., a Florida company with “conditional”…

News April 13

Image of a pile of $100 bills

Marijuana financier Pelorus lends nearly $17M to Royal Emerald Pharmaceuticals

Marijuana real estate lender Pelorus Equity Group announced debt financing worth nearly $17 million to specialty-drug company Royal…

News March 8

Second US cannabis company uplisted to NYSE to begin trading Tuesday

Image of DEA agent badge

Why cannabis businesses need to apply for DEA registration now – and why states must help

Image of a partially open bank vault door with a glowing light emanating from within

Bipartisan lawmakers reintroduce SAFER Banking on eve of marijuana rescheduling hearings

Image of Miguel Martin

How Aurora Cannabis plans to enter the US market

Image of DEA Chief Administrative Law Judge John Mulrooney II overseeing Monday's marijuana rescheduling hearing

What to expect from the DEA marijuana rescheduling hearing

Macro image of a cannabis bud

Cannabis loyalty isn’t built on THC, it’s built on trust

1

Image of a "For Lease" sign in front of a vacant business space

Green Life Business Group brokers the cannabis industry’s biggest deals

The New Genetics Race: Why Cannabis Seed Brands Are Becoming the Next Big Differentiator

The Medical Card Has a New Argument

Leveling the Legal Playing Field

Hemp’s Regulatory Reckoning: A Patchwork States Can’t Sustain